2026-06-05 09:16:36
Latest Post
Alembic Pharmaceuticals Appoints Mr. Ramesh Juneja as Executive Vice President - Human Health (Sales and Marketing), India Business
Second Half Recovery Limits Nifty Losses to 78 Points; IT Index Tanks 5.5%
Akums Receives European CEP Approval for Cefpodoxime Proxetil
Tunwal E-Motors Reports Strong FY26 Results; Revenue Surges 55% to ₹276.84 Crore
Sharika Enterprises Enters High-Growth SCADA-ADMS Market with Uttarakhand Grid Modernization Project
Research
Buy Areva T&D, Kotak Securities
Posted On : 2006-10-31 05:40:24( TIMEZONE : IST )
Kotak Securities Private Client Research has upgraded the rating on Areva T&D to Buy with a price target of Rs.935. The current market price of the stock is Rs.802.